Improve accuracy of lung cancer invasiveness diagnosis during surgery
Part of Cancer clinical trials.
This trial looks to improve how doctors judge how “invasive” a small lung adenocarcinoma is while you’re having surgery. Better accuracy may help guide treatment decisions for people with early-stage, operable lung cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a CT scan within 3 months before your lung surgery
- You are age 20 to 80, and your lung cancer is operable and stage I
- Your lung tumor is under 3 cm, measured on thin CT slices
- Your tumor is confirmed as lung adenocarcinoma after surgery by pathology (tissue testing)
- You have not had cancer treatment before (in the lungs or elsewhere)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how well a computer model predicts which lymph nodes need to be removed during lung cancer surgery. If you have early-stage lung cancer that can be removed, you may be eligible.
This study looks at whether people with a very early type of lung cancer can safely have curative surgery when their CT scan shows a ground-glass type spot with certain size and shape measurements. It aims to help doctors choose the right surgery approach based on the scan features and final pathology.
This trial is testing a lung-sparing surgery called segmentectomy for people with a certain type of lung cancer nodule. It aims to see if this surgery is a good option for those with solid-dominant nodules that are 2 to 3 cm in size and have not spread to lymph nodes.
This study uses a special type of CT scan (dual energy CT) to look at lung nodules that are 3 cm or smaller and have been confirmed as lung adenocarcinoma. The goal is to see if the scan can help tell how aggressive the cancer is, which may guide treatment decisions.
This trial studies if a limited surgery (wedge resection) works well for small lung cancers that appear as ground-glass opacities on CT scans. It aims to remove the tumor while preserving more lung tissue.
This study looks at CT scans from people with early-stage lung cancer to see if we can predict if the cancer might have spread through the air spaces in the lung. It aims to help doctors decide on better treatment after surgery.
Hear when a new Lung Adenocarcinoma, Stage I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.